Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

998 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma.
Kennedy OJ, Glassee N, Kicinski M, Blank CU, Long GV, Atkinson VG, Dalle S, Haydon AM, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Boers-Sonderen M, Giacomo AMD, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, van Akkooi ACJ, Gandini S, Buhrer E, Suciu S, Robert C, Eggermont AMM, Mandala M, Lorigan P, Valpione S. Kennedy OJ, et al. Among authors: puig s. Eur J Cancer. 2024 Apr;201:113585. doi: 10.1016/j.ejca.2024.113585. Epub 2024 Feb 1. Eur J Cancer. 2024. PMID: 38402687 Clinical Trial.
Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy.
Kött J, Zimmermann N, Zell T, Rünger A, Heidrich I, Geidel G, Smit DJ, Hansen I, Abeck F, Schadendorf D, Eggermont A, Puig S, Hauschild A, Gebhardt C. Kött J, et al. Among authors: puig s. Eur J Cancer. 2024 May;202:113989. doi: 10.1016/j.ejca.2024.113989. Epub 2024 Mar 8. Eur J Cancer. 2024. PMID: 38518535 Free article. Review.
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study).
Mandalà M, Ferrari A, Brecht IB, Suijkerbuijk KP, Maschke L, Giannarelli D, Indini A, Ubaldi M, Pecci G, Atkinson V, Helgadottir H, Chiaravalli S, Benannoune N, Robert C, Teterycz P, Rutkowski P, Puig S, Madonna G, Kebudi R, Grynberg S, Arantes LM, Bien E, Krawczyk M, Pasquale MD, Dierselhuis MP, Massi D, Long GV, Ascierto PA, Eggermont AMM; Melcaya consortium (see appendix for the list of the coauthors belonging to the Melcaya Consortium). Mandalà M, et al. Among authors: puig s. Eur J Cancer. 2024 Nov;211:114305. doi: 10.1016/j.ejca.2024.114305. Epub 2024 Sep 3. Eur J Cancer. 2024. PMID: 39236557 Free article.
Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results.
Indini A, Didoné F, Massi D, Puig S, Casadevall JR, Bennett D, Katalinic A, Sanvisens A, Ferrari A, Lasalvia P, Demuru E, Ragusa R, Mayer-da-Silva A, Blum M, Mousavi M, Kuehni C, Mihor A, Mandalà M, Trama A; EUROCARE-6 Working Group. Indini A, et al. Among authors: puig s. Eur J Cancer. 2024 Dec;213:115079. doi: 10.1016/j.ejca.2024.115079. Epub 2024 Oct 24. Eur J Cancer. 2024. PMID: 39546860 Free article.
Access to melanoma drugs in Spain: a cross-sectional survey.
Gonzalez-Cao M, Puertolas T, Manzano JL, Maldonado C, Yelamos O, Berciano-Guerrero MÁ, Cerezuela P, Martin-Liberal J, Muñoz-Couselo E, Espinosa E, Drozdowskyj A, Berrocal A, Soria A, Marquez-Rodas I, Martin-Algarra S, Quindos M, Puig S; Spanish Melanoma Group (GEM). Gonzalez-Cao M, et al. Among authors: puig s. Clin Transl Oncol. 2024 Oct;26(10):2572-2583. doi: 10.1007/s12094-024-03501-9. Epub 2024 May 16. Clin Transl Oncol. 2024. PMID: 38750345
Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience.
Moysset I, Castrejon N, Garcia-Herrera A, Castillo P, Marginet M, Teixido C, Podlipnik S, Albero-Gonzalez R, Montironi C, Navarro J, Rovira C, Puig S, Carrera C, Alos L. Moysset I, et al. Among authors: puig s. Histopathology. 2024 Jun;84(7):1154-1166. doi: 10.1111/his.15160. Epub 2024 Feb 26. Histopathology. 2024. PMID: 38409889
Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis.
Cerezuela-Fuentes P, Gonzalez-Cao M, Puertolas T, Manzano JL, Maldonado C, Yelamos O, Berciano-Guerrero MA, Martin-Liberal J, Muñoz-Couselo E, Espinosa E, Drozdowskyj A, Berrocal A, Soria A, Marquez-Rodas I, Martin-Algarra S, Quindos M, Puig S; Spanish Melanoma Group (GEM). Cerezuela-Fuentes P, et al. Among authors: puig s. Clin Transl Oncol. 2025 Jan;27(1):386-391. doi: 10.1007/s12094-024-03583-5. Epub 2024 Jul 1. Clin Transl Oncol. 2025. PMID: 38951438
998 results